Telephone Contact Between Hospital and General Practitioner About Medication Review for Older Patients

NCT03369652 | Completed DMC

• 2 other identifiers: OP_4681704197
• Study Type: interventional
• Target: 232
• Locations: 1 country
• Sites: 2

Brief Summary

In this trial, the feasibility of cooperation between clinical pharmacists and physicians by conducting a telephone follow-up conversation between the hospital geriatrician, the general practitioner and the clinical pharmacist is evaluated. During hospital stay the clinical pharmacist and the geriatrician will review older patients' medication and discuss the future treatment with the general practitioner after discharge by telephone or medico-technology. The first part of the feasibility study will be a qualitative baseline measure of characteristics of the participants and work flow. The second part will be a pilot randomized controlled study where participants will be allocated to either usual care or medication review and follow up contact

Conditions

Older Patients; Medication Review; Cross-sectional Communication

Outcome Measures

Primary Outcomes (3)

• Changes in number of medications

  Increase or decrease in number of medications from admission to discharge

  At admission and at discharge

• Parts of the intervention completed

  In the intervention Group only, it is measured, how many of the elements of the intervention the patient actually have received

  Day 1 after discharge

• Changes in the Electronic Medication Profile (FMK)

  How many changes have been Applied to the Electronic Medication Profile

  14 days after discharge

Secondary Outcomes (6)

• Number of readmissions

  within 30 days after discharge

• Number of emergency visits

  within 30 days after discharge

• Number of visits at general practitioner

  within 30 days after discharge

• Patient satisfaction with the discharge

  14 days after discharge

• Changes in patient-experienced quality of life

  At admission and 14 days after discharge

Study Arms (2)

Intervention

EXPERIMENTAL

Medication history by pharmaconomist. Medication review by pharmacist, patient interview, and conference with physician in hospital, telephone contact to general practitioner after discharge, medication report sent to primary care.

Behavioral: Medication review

Control

NO INTERVENTION

Medication history by pharmaconomist. Usual care by physicians.

Interventions

Medication review BEHAVIORAL

Conducted by the pharmacist and discussed with hospital physician

Intervention

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• \* 5 drugs or more

You may not qualify if:

• Terminal illness
• Not able to speak and understand Danish

Sponsors & Collaborators

• Odense University Hospital: lead

Study Sites (2)

Odense University Hospital

Odense, 5000, Denmark

Location

Svendborg Sygehus

Svendborg, Denmark

Location

MeSH Terms

Interventions

Medication Review

Intervention Hierarchy (Ancestors)

Medication Systems; Organization and Administration; Health Services Administration; Patient Care Management

Study Officials

• Anton Pottegård, phd

  University of Southern Denmark

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Pharmacist

Study Record Dates

• First Submitted: November 21, 2017
• First Posted: December 12, 2017
• Study Start: November 24, 2017
• Primary Completion: November 1, 2018
• Study Completion: November 30, 2018
• Last Updated: March 19, 2019

Record last verified: 2019-03

Data Sharing

• IPD Sharing: Will not share

Locations

DK (2)